Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07660432
What this trial is testing

SIM0689 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Neoplasms, Malignant
Jiangsu Simcere Pharmaceutical Co., Ltd. 472
Testing effectiveness (Phase 2)Study completedNCT03560531
What this trial is testing

ZN-c5 in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 181
Early research (Phase 1)Looking for participantsNCT06801002
What this trial is testing

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

Who this might be right for
Solid Tumor
Jabez Bioscience, Inc 25
Not applicableStudy completedNCT01254669
What this trial is testing

An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls

Who this might be right for
Cervical Cancer
Boston Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Large-scale testing (Phase 3)Looking for participantsNCT06452277
What this trial is testing

Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer 555
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698080
What this trial is testing

Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaThalassemia+2 more
Hematology department of the 920th hospital 60
Not applicableActive Not RecruitingNCT06286956
What this trial is testing

Rectal Tumor Resection Using the UNI-VEC Multichannel Transanal Access Device

Who this might be right for
Rectal PolypRectal PolypsRectal Lesion+2 more
Vecmedical Spain, S.L. 40
Testing effectiveness (Phase 2)Study completedNCT04542356
What this trial is testing

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

Who this might be right for
Cervical Cancer
Chongqing University Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT04466137
What this trial is testing

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Who this might be right for
Non-Myeloid Malignancy
Xiamen Amoytop Biotech Co., Ltd. 398
Not applicableLooking for participantsNCT06902545
What this trial is testing

Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Korea, Inc.
Not applicableNot Yet RecruitingNCT07104253
What this trial is testing

Establishing Feasibility of Transbronchial Cryoablation With an In-Development Cryoprobe: An Ex-Vivo Human Lung Model

Who this might be right for
Lung Cancer
Endocision Technologies Inc. 10
Large-scale testing (Phase 3)Study completedNCT05507645
What this trial is testing

ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)

Who this might be right for
Ischemic StrokeMildThrombosis
Beijing Tiantan Hospital 1,446
Early research (Phase 1)WithdrawnNCT02921373
What this trial is testing

Tracking Peripheral Blood Mononuclear Cells With Fluorine MRI

Who this might be right for
Adverse Reaction to Diagnostic Agents and Kits Nos
Gregory A. Dekaban
Early research (Phase 1)Study completedNCT01972737
What this trial is testing

Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer

Who this might be right for
Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10
Not applicableActive Not RecruitingNCT06611553
What this trial is testing

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

Who this might be right for
Cervical CarcinomaHuman Papillomavirus Infection
National Cancer Institute (NCI) 500
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Not applicableActive Not RecruitingNCT05064553
What this trial is testing

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more
Exact Sciences Corporation 2,990
Large-scale testing (Phase 3)Study completedNCT01418937
What this trial is testing

Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 164
Testing effectiveness (Phase 2)Ended earlyNCT02753595
What this trial is testing

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Eisai Inc. 25
Next Page
377